Dengue fever is a viral infectious disease that mainly occurs in tropical regions. Spread by Aedes species mosquito, Dengue virus infects millions of people every year.

Dengue viruses can divide into 1-4 serotypes based on the antigenicity of viral envelope protein E. Antigenic determinants of viral envelope protein E can induce the production of protective neutralizing antibodies and hemagglutination suppressive antibodies and may be involved in the development of Dengue hemorrhagic fever (DHF) and Dengue shock syndrome (DSS).

SEKBIO developed multiple antigens and antibodies for Dengue ab fever diagnostics, including Dengue NS1 Antibody, Recombinant Dengue Type I NS1 protein, Recombinant Dengue Type II NS1 protein, Recombinant Dengue Type III NS1 protein, Recombinant Dengue Type IV NS1 protein.

Dengue Products

Antibody Application

Dengue NS1 Antibody For immunodiagnostic: ELISA, LFA, CLIA

Antigen Application

Recombinant Dengue Type I NS1 Protein For immunodiagnostic: ELISA, LFA, CLIA

Recombinant Dengue Type II NS1 Protein

Recombinant Dengue Type III NS1 Protein

Recombinant Dengue Type IV NS1 Protein

Dengue Antibody

Dengue fever is an acute insect-borne infectious disease caused by the mosquito-borne dengue virus. Dengue virus infection can lead to latent infection, dengue fever, and dengue hemorrhagic fever. The typical clinical manifestations of dengue fever are rapid onset, high fever, headache, severe pain in muscles, bones, joints, skin rash, bleeding tendency, swollen lymph nodes, decreased white blood cell count, and thrombocytopenia in some patients. Dengue hemorrhagic fever is rare in my country.